{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:18:31Z","timestamp":1772738311535,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most existing studies have predominantly examined the impact of single blood glucose measurements without considering how fluctuations over time may influence clinical outcomes. Moreover, no studies have yet explored the effect of blood glucose trajectories on pathological responses in breast cancer patients undergoing neo-adjuvant chemotherapy (NACT), highlighting a significant gap in the current literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine the impact of dynamic changes in blood glucose during neo-adjuvant chemotherapy on the pathological responses in women with breast cancer, with and without concomitant diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This prospective cohort study was conducted among women with locally advanced breast cancer receiving treatment at GINUM Hospital in Gujranwala, Pakistan. Data for the prospective phase were collected from 20 January 2023 to\u201313 May 2024. Clinical data were obtained using a structured data collection form. Diabetes status was confirmed at baseline using Glycated hemoglobin (HbA1c) and Fasting blood glucose (FBG) tests. Patients were classified into glycemic trajectories based on the values of their FBG values during the treatment period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five blood glucose trajectories were identified from the start of breast cancer treatment to the post-treatment period: normal glycemic trajectory (23 patients, 4.1%), erratic glycemic trajectory (130 patients, 23.2%), consistently hyperglycemic trajectory (127 patients, 22.7%), controlled diabetes (130 patients, 23.2%), and uncontrolled diabetes (150 patients, 26.8%). All glycemic trajectory groups demonstrated a non-significant increase in the odds of achieving Pathological partial response (pPR). Similar to pPR, the various categories of blood glucose trajectories were associated with a non-significant increase in the odds of Pathological no response (pNR). Among nondiabetic patients the group I(normal) and group III (consistently hyperglycemic) trajectories showed no significant interaction with pathological responses, as indicated by repeated measures ANOVA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicated that fluctuations in FBG levels among individuals with diabetes were not associated with pathological responses to neo-adjuvant chemotherapy. This suggests that the rise in blood glucose levels in diabetic patients are more likely driven by their pre-existing metabolic dysfunction rather than their chemotherapy related pathological responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0319314","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:35:02Z","timestamp":1772735702000},"page":"e0319314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycemic trajectories of fasting blood glucose on the pathological responses in breast cancer women with and without concomitant diabetes"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6263-7704","authenticated-orcid":true,"given":"Saba","family":"Javed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dzul Azri","family":"Mohamed Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-0705","authenticated-orcid":true,"given":"Nur Hafzan Md","family":"Hanafiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanveer","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabariah","family":"Noor Harun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"2","key":"pone.0319314.ref001","doi-asserted-by":"crossref","DOI":"10.52225\/narrax.v1i2.86","article-title":"Cancer in Indonesia: A bibliometric surveillance","volume":"1","author":"M Iqhrammullah","year":"2023","journal-title":"Narra X"},{"issue":"3","key":"pone.0319314.ref002","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v3i3.326","article-title":"Cytotoxic activity of ethyl acetate extract of Chromolaena odorata on MCF7 and T47D breast cancer cells","volume":"3","author":"H Yusuf","year":"2023","journal-title":"Narra J"},{"issue":"5","key":"pone.0319314.ref003","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.31557\/APJCP.2023.24.5.1561","article-title":"Breast Cancer Awareness and Associated Factors among Women in Pakistan: A Cross-Sectional Descriptive Study","volume":"24","author":"Z Shoukat","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"pone.0319314.ref004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","article-title":"Diabetes mellitus and breast cancer","volume":"6","author":"I Wolf","year":"2005","journal-title":"Lancet Oncol"},{"issue":"49","key":"pone.0319314.ref005","article-title":"Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis","volume":"95","author":"X-B Zhao","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"pone.0319314.ref006","first-page":"308","article-title":"Glycemic variability and microvascular complications of diabetes","volume":"156","author":"M Pr\u00e1zn\u00fd","year":"2017","journal-title":"Cas Lek Cesk"},{"issue":"3","key":"pone.0319314.ref007","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.202007-2634OC","article-title":"Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China","volume":"204","author":"Q Liu","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"pone.0319314.ref008","first-page":"2095","article-title":"Increased red blood cell distribution width (RDW) is associated with higher glycosylated hemoglobin (HbA1c) in the elderly","volume":"60","author":"G Lippi","year":"2014","journal-title":"Clin Lab"},{"key":"pone.0319314.ref009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"DS Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"1","key":"pone.0319314.ref010","article-title":"Medical care in diabetes","volume":"41","author":"C Diabetes","year":"2018","journal-title":"Diabet Care"},{"issue":"7","key":"pone.0319314.ref011","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/infdis\/jiv568","article-title":"Transient Hyperglycemia in Patients With Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms","volume":"213","author":"N Boillat-Blanco","year":"2016","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0319314.ref012","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2337\/dc14-2898","article-title":"Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!","volume":"38","author":"IB Hirsch","year":"2015","journal-title":"Diabetes Care"},{"issue":"8","key":"pone.0319314.ref013","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1464-5491.2010.02967.x","article-title":"\u201cGlycaemic variability\u201d: a new therapeutic challenge in diabetes and the critical care setting","volume":"27","author":"A Ceriello","year":"2010","journal-title":"Diabet Med"},{"issue":"8","key":"pone.0319314.ref014","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"LA Carey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"pone.0319314.ref015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12885-016-2500-1","article-title":"Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II\/III breast cancer patients: breast cancer subtype analyses","volume":"16","author":"Y Yang","year":"2016","journal-title":"BMC Cancer"},{"issue":"21","key":"pone.0319314.ref016","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.3390\/cancers13215477","article-title":"Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review","volume":"13","author":"AJA de Freitas","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"pone.0319314.ref017","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1245\/s10434-012-2756-x","article-title":"Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer","volume":"20","author":"B Keam","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"pone.0319314.ref018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3348\/kjr.2018.0231","article-title":"Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage","volume":"20","author":"J Koh","year":"2019","journal-title":"Korean J Radiol"},{"key":"pone.0319314.ref019","doi-asserted-by":"crossref","first-page":"732027","DOI":"10.1155\/2012\/732027","article-title":"Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients","volume":"2012","author":"C Villarreal-Garza","year":"2012","journal-title":"Exp Diabetes Res"},{"issue":"4","key":"pone.0319314.ref020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"P Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"pone.0319314.ref021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jdiacomp.2018.12.012","article-title":"Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy","volume":"33","author":"D Zylla","year":"2019","journal-title":"J Diabetes Complications"},{"issue":"8","key":"pone.0319314.ref022","first-page":"563","article-title":"Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists\u2019 practices","volume":"32","author":"TM Salgado","year":"2024","journal-title":"Support Care Cancer"},{"issue":"6","key":"pone.0319314.ref023","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4103\/apjon.apjon-2131","article-title":"Glycemic Excursion, Adverse Drug Reactions, and Self-Management in Diabetes Patients Undergoing Chemotherapy: A Literature Review","volume":"8","author":"N Terao","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"5","key":"pone.0319314.ref024","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/jcm12051906","article-title":"Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer","volume":"12","author":"D Mahin","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"pone.0319314.ref025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-025-07745-z","article-title":"Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer","volume":"212","author":"SR Ulene","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"pone.0319314.ref026","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4048\/jbc.2020.23.e44","article-title":"Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast Cancer Patients without Diabetes","volume":"23","author":"HR Ahn","year":"2020","journal-title":"J Breast Cancer"},{"issue":"11","key":"pone.0319314.ref027","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/14740338.2022.2151584","article-title":"Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects","volume":"21","author":"P Di Nardo","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"pone.0319314.ref028","doi-asserted-by":"crossref","first-page":"107987","DOI":"10.1016\/j.diabres.2019.107987","article-title":"Glycemic variability and subsequent malignancies among the population without diabetes","volume":"159","author":"D Kobayashi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0319314.ref029","doi-asserted-by":"crossref","unstructured":"Mortimer J, Mahin D, Lavasani SM, Cristobal L, Patel NT, Sedrak M, et al. Hyperglycemia and glycemic variability associated with glucocorticoids in women without pre-existing diabetes undergoing (neo) adjuvant taxane chemotherapy for early-stage breast cancer. 2022.","DOI":"10.21203\/rs.3.rs-1582338\/v1"},{"issue":"3","key":"pone.0319314.ref030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10549-013-2519-9","article-title":"Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study","volume":"138","author":"P Contiero","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"pone.0319314.ref031","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bj.2018.10.007","article-title":"Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy","volume":"42","author":"H-H Chou","year":"2019","journal-title":"Biomed J"},{"issue":"20","key":"pone.0319314.ref032","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"S Jiralerspong","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:35:07Z","timestamp":1772735707000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319314"}},"subtitle":[],"editor":[{"given":"Muhammad","family":"Tariq","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}